|
WO2015082721A1
|
|
MEANS AND METHODS FOR ESTABLISHING A CLINICAL PROGNOSIS OF DISEASES ASSOCIATED WITH THE FORMATION OF AGGREGATES OF Aβ1-42
|
|
EP2721035A1
|
|
Glioblastoma inhibiting compounds and their use
|
|
EP2465859A1
|
|
8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists
|
|
EP2411034A1
|
|
Promotion of neuronal integration in neural stem cell grafts
|
|
DE102009051276A1
|
|
In-vivo stimulation probe
|
|
AU2009291203A1
|
|
Peripheral zone tumor cells, methods for their preparation and use
|
|
WO2009149956A2
|
|
Fusion protein and use thereof
|
|
WO2010108503A1
|
|
Promotion of neuronal integration in neural stem cell grafts
|
|
EP2108704A1
|
|
Androgenetic alopecia
|
|
EP2042514A1
|
|
Maintenance of hair growth and treatment of hair-loss
|
|
WO2006111424A1
|
|
Methods for identifying modulators of cb1 and cb2 cannabinoid receptors and their use in wound healing
|
|
US2005272149A1
|
|
Therapeutic delivery of adenosine into a tissue
|
